No Data
Johnson & Johnson Is Maintained at Outperform by RBC Capital
Johnson & Johnson Analyst Ratings
Verb Surgical Granted US Patent # 12,108,928 B2 For MACHINE-LEARNING-BASED VISUAL-HAPTIC SYSTEM FOR ROBOTIC SURGICAL PLATFORMS
Johnson & Johnson's (NYSE:JNJ) Has Had A Decent Run On The Stock Market: Are Fundamentals In The Driver's Seat?
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $178
Goldman Sachs Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $162
loading...
loading...
JackChng : Wow. Next time I just follow your way
ひな☆彡 SOXL OP JackChng : Confirm with your strategy and enter. Use my entry as a reference.
CLL : Walk with these footsteps of yours
ひな☆彡 SOXL OP CLL : Sorry past few moves are garbage
CLL : No, bought a few and all of them are good.
View more comments...